benefits of glp-1 agonists Frontiers GLP-1 Agonists Transform Diabetes &
Description
Short-acting drugs include exenatide twice daily, lixisenatide once daily and oral semaglutide once daily, while long-acting drugs include liraglutide, semaglutide, exenatide, albiglutide and dulaglutide all being administered once weekly
A BMI of 27 or higher contributes to high blood pressure, cholesterol, or sleep apnea
Among these, osteoprotegerin (OPG), receptor activator for nuclear factor-B ligand (RANKL), and receptor activator for nuclear factor-B form a triangular relationship that regulates osteoclast differentiation, activation, and apoptosis
Influence of maternal body mass index on pregnancy complications and outcomes: a systematic review and meta-analysis
2024;16:e66280
